Related Experiment Video
Updated: Aug 13, 2026
Isolation of Primary Myofibroblasts from Mouse and Human Colon Tissue
Published on: October 13, 2013
Beta 2-microglobulin induces stromelysin production by human synovial fibroblasts
K Migita1, K Eguchi, M Tominaga
1The First Department of Internal Medicine, Nagasaki University School of Medicine, Japan. eguchi@net.nagasaki-u.ac.jp
Abstract:
beta 2-Microglobulin (beta 2-m) is a major constituent of amyloid fibrils in hemodialysis-associated amyloidosis (HAA), a serious complication in patients on long-term hemodialysis. The most distinctive pathological feature of HAA is the deposition of amyloid fibrils with subsequent articular inflammation and destruction. However, the pathological role of beta 2-m is not well known at present. We investigated the effects of beta 2-m on the production of proteinases from synovial fibroblasts isolated from patients with rheumatoid arthritis. beta 2-m stimulated synovial fibroblasts to produce stromelysin, a neutral matrix metalloproteinase (MMP-3). The production of MMP-2 and of a tissue inhibitor of metalloproteinase-1 (TIMP-1) were not enhanced by beta 2-m-treated synovial fibroblasts. Stromelysin is capable of degrading several components of the extracellular matrix and believed to be the key enzyme causing articular destruction in inflammatory joint diseases. Our results suggest a novel role for beta 2-m in articular inflammation and destruction mediated by stromelysin in HAA.
Insights
Beta 2-microglobulin (beta 2-m) drives joint destruction in hemodialysis-associated amyloidosis (HAA). This protein stimulates synovial fibroblasts to produce stromelysin, a key enzyme in articular damage.
Area of Science:
- Biochemistry
- Rheumatology
- Nephrology
Background:
- Beta 2-microglobulin (beta 2-m) is a major component of amyloid fibrils in hemodialysis-associated amyloidosis (HAA).
- HAA is a severe complication in patients undergoing long-term hemodialysis, characterized by amyloid deposition, joint inflammation, and destruction.
- The precise pathological role of beta 2-m in HAA pathogenesis remains unclear.
Purpose of the Study:
- To investigate the effects of beta 2-m on proteinase production by synovial fibroblasts.
- To elucidate the role of beta 2-m in the articular inflammation and destruction seen in HAA.
Main Methods:
- Synovial fibroblasts were isolated from patients with rheumatoid arthritis.
- These fibroblasts were treated with beta 2-m.
- The production of matrix metalloproteinases (MMPs) and their inhibitors was analyzed.
Main Results:
- Beta 2-m significantly stimulated synovial fibroblasts to produce stromelysin (MMP-3).
- Beta 2-m did not enhance the production of MMP-2 or tissue inhibitor of metalloproteinase-1 (TIMP-1).
- Stromelysin is known to degrade extracellular matrix components and is implicated in joint destruction.
Conclusions:
- Beta 2-m plays a novel role in mediating articular inflammation and destruction in HAA.
- This effect appears to be driven by beta 2-m-induced stromelysin production.
- Targeting stromelysin may offer a therapeutic strategy for HAA-related joint damage.
